Supplement: MD SB740 | 2016 | Regular Session | Fiscal Note/Analysis
For additional supplements on Maryland SB740 please see the Bill Drafting List
Bill Title: Business Regulation - Marketing Synthetic Drugs - Penalties
Status: 2016-03-24 - Unfavorable Report by Finance [SB740 Detail]
Download: Maryland-2016-SB740-Fiscal_Note-Analysis.pdf
Bill Title: Business Regulation - Marketing Synthetic Drugs - Penalties
Status: 2016-03-24 - Unfavorable Report by Finance [SB740 Detail]
Download: Maryland-2016-SB740-Fiscal_Note-Analysis.pdf